How to buy Bausch Health Companies stock (BHC)

Bausch Health Companies is a drug manufacturers - specialty & generic business based in the US. Bausch Health Companies shares (BHC) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $7.47 – a decrease of 4.35% over the previous week. Bausch Health Companies employs 20,270 staff and has a trailing 12-month revenue of around $9.5 billion.

Our top picks for where to buy Bausch Health Companies stock

Buy Bausch Health Companies stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Bausch Health Companies stock price (NYSE: BHC)

Use our graph to track the performance of BHC stocks over time.

Bausch Health Companies shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$7.47
52-week range	$3.96 - $11.46
50-day moving average more info button	$8.36
200-day moving average more info button	$7.65
Wall St. target price	$8.57
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.48

Is it a good time to buy Bausch Health Companies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Bausch Health Companies price performance over time

Historical closes compared with the close of $7.47 from 2024-12-20

1 week (2024-12-16)	-2.35%
1 month (2024-11-22)	-6.27%
3 months (2024-09-23)	-6.74%
6 months (2024-06-21)	9.85%

1 year (2023-12-22)	0.27%
2 years (2022-12-23)	18.01%
3 years (2021-12-23)	27.99
5 years (2019-12-23)	29.91

Is Bausch Health Companies stock undervalued or overvalued?

Valuing Bausch Health Companies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bausch Health Companies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Bausch Health Companies's PEG ratio

Bausch Health Companies's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.6315. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Bausch Health Companies's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Bausch Health Companies's EBITDA

Bausch Health Companies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.1 billion.

The EBITDA is a measure of a Bausch Health Companies's overall financial performance and is widely used to measure a its profitability.

Bausch Health Companies financials

Revenue TTM	$9.5 billion
Operating margin TTM	21.67%
Gross profit TTM	$5.8 billion
Return on assets TTM	4.15%
Return on equity TTM	-2304.54%
Profit margin	-1.88%
Book value	$-3.19
Market Capitalization more info button	$2.7 billion

TTM: trailing 12 months

Bausch Health Companies share dividends

We're not expecting Bausch Health Companies to pay a dividend over the next 12 months.

Have Bausch Health Companies's shares ever split?

Bausch Health Companies's shares were split on a 2:1 basis on 15 October 2000 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Bausch Health Companies shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Bausch Health Companies shares which in turn could have impacted Bausch Health Companies's share price.

Bausch Health Companies share price volatility

Over the last 12 months, Bausch Health Companies's shares have ranged in value from as little as $3.96 up to $11.46. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Bausch Health Companies's is 0.745. This would suggest that Bausch Health Companies's shares are less volatile than average (for this exchange).

Bausch Health Companies overview

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices.

Frequently asked questions

null
What percentage of Bausch Health Companies is owned by insiders or institutions?
Currently 11.066% of Bausch Health Companies shares are held by insiders and 72.022% by institutions. How many people work for Bausch Health Companies?
Latest data suggests 20,270 work at Bausch Health Companies. When does the fiscal year end for Bausch Health Companies?
Bausch Health Companies's fiscal year ends in December. Where is Bausch Health Companies based?
Bausch Health Companies's address is: 2150 St. ElzEar Boulevard West, Laval, QC, Canada, H7L 4A8 What is Bausch Health Companies's ISIN number?
Bausch Health Companies's international securities identification number is: CA0717341071 What is Bausch Health Companies's CUSIP number?
Bausch Health Companies's Committee on Uniform Securities Identification Procedures number is: 09067J109